CGNT Abuzz, Retrophin's DUET Hits Right Notes, Watch Out For RPRX

The phase II results of Repros Therapeutics Inc.'s (RPRX) oral Proellex for the treatment of premenopausal women with confirmed symptomatic endometriosis, announced Wednesday, are encouraging.

from RTT - Biotech http://ift.tt/2cmhrsJ
via IFTTT